Polycarbin’s Post

Sustainability is rising to the top of the global agenda as regulations are evolving and investors, customers, and talent demand more transparency from companies on the topic. GEN highlighted insights from our 2024 Global Biopharma Sustainability Review. Check out these insights now.

Sustainability is rising to the top of the global agenda as regulations are evolving and investors, customers, and talent demand more transparency from companies on the topic. GEN highlighted insights from our 2024 Global Biopharma Sustainability Review. Check out these insights now.

Sustainability is rising to the top of the global agenda as regulations are evolving and investors, customers, and talent demand more transparency from companies on the topic. GEN highlighted insights from our 2024 Global Biopharma Sustainability Review. Check out these insights now.

Sustainability is rising to the top of the global agenda as regulations are evolving and investors, customers, and talent demand more transparency from companies on the topic. GEN highlighted insights from our 2024 Global Biopharma Sustainability Review. Check out these insights now.

Sustainability is rising to the top of the global agenda as regulations are evolving and investors, customers, and talent demand more transparency from companies on the topic. GEN highlighted insights from our 2024 Global Biopharma Sustainability Review. Check out these insights now.

Sustainability is rising to the top of the global agenda as regulations are evolving and investors, customers, and talent demand more transparency from companies on the topic. GEN highlighted insights from our 2024 Global Biopharma Sustainability Review. Check out these insights now.

🌱 Sustainability is now at the core of biopharma industry, with 62% of executives saying it's a top priority for the next 5 years. How do we know? We asked 800 biopharma leaders across 18 countries about their sustainability focus and progress so far. We know this document is packed with insights, download it for later. 👇

Sustainability in Pharma: A Strategic Imperative What: Sustainability in the pharmaceutical industry involves reducing environmental impact, ethical sourcing, energy efficiency, waste reduction, and adopting sustainable practices across the supply chain. Why: It’s essential to address environmental challenges, meet regulatory demands, and respond to increasing customer and stakeholder expectations. Sustainability is not just a responsibility but a pathway to innovation, trust, and long-term growth. How: Implementing green technologies, minimizing waste, using renewable resources, ensuring ethical supply chains, and optimizing energy use. Collaboration with suppliers, employees, and communities is key to embedding sustainability in every step of the process. When: The time to act is now. As regulations evolve and consumer awareness grows, embracing sustainability today positions us ahead of the curve, ensuring compliance and market leadership. Value: Company: Enhances brand reputation, drives cost efficiency, fosters innovation, and ensures regulatory compliance. Customers & Patients: Provides safer, more sustainable products, aligning with their values and needs. Suppliers: Strengthens partnerships through shared sustainability goals and responsible practices. Employees: Boosts morale and engagement by aligning work with personal values and global responsibility. Society: Contributes to healthier communities and a sustainable future for the planet. Sustainability isn't just an option—it's a necessity for a thriving future. Let's lead the change together. 🌱

Sustainability in BioPharma isn't just a buzzword—it's a responsibility. In an industry dedicated to saving lives, it's vital to acknowledge that our efforts can also contribute to saving the planet. With over 70% of healthcare emissions tied to supply chains, there's a clear opportunity to make a difference. By embracing sustainable practices and innovative technologies, we can create a healthier world in every sense. For those interested in diving deeper, I encourage you to read this article by Deloitte that dives a bit deeper: https://lnkd.in/drGPUNwh #Sustainability #BioPharma #HealthcareInnovation #ESG

Sustainability is rising to the top of the global agenda as regulations are evolving and investors, customers, and talent demand more transparency from companies on the topic. GEN highlighted insights from our 2024 Global Biopharma Sustainability Review. Check out these insights now.